Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Sup Lee

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
The Lancet Regional Health. Western Pacific|July 30, 2021
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in AsiaSang Eun Yoon, Yuqin Song, Seok Jin Kim, et al.
International Journal of Hematology|July 24, 2021
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in AsiaYong-Pyo Lee, Sang Eun Yoon, Yuqin Song, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Blood Research|April 8, 2025
Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Acta Haematologica|September 26, 2018
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple MyelomaGyeong-Won Lee, Sung Woo Park, Se-Il Go, et al.
Oncotarget|April 14, 2017
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myelomaMin Kyoung Kim, Kihyun Kim, Chang-Ki Min, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
The Lancet Regional Health. Western Pacific|July 30, 2021
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in AsiaSang Eun Yoon, Yuqin Song, Seok Jin Kim, et al.
International Journal of Hematology|July 24, 2021
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in AsiaYong-Pyo Lee, Sang Eun Yoon, Yuqin Song, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Blood Research|February 4, 2025
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Blood Research|April 8, 2025
Correction: Evidence‑based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questionsSung-Hoon Jung, Youngil Koh, Min Kyoung Kim, et al.
Acta Haematologica|September 26, 2018
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple MyelomaGyeong-Won Lee, Sung Woo Park, Se-Il Go, et al.
Oncotarget|April 14, 2017
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myelomaMin Kyoung Kim, Kihyun Kim, Chang-Ki Min, et al.
Pageof 14